TRPV1 and Alzheimer disease: However, it is difficult to use an IL-31RA expression inhibitor, such as tacrolimus, along with TRPV1 stimulation as a therapeutic drug, as a patient with AD experienced severe pain immediately after its application (Pereira et al. (2010)).